Saturn V Capital Management LP Diversified Active

Location: Austin, TX

CIK: 0001964437 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 13, 2025

Total Value: $247M (100.0% shares, 0.0% debt)

Holdings (24)

JAZZ JAZZ PHARMACEUTICALS PLC 8.9%

Value $21.96M Shares 206,952 Est. Cost $108.63 Unrealized 0.0%

IRON DISC MEDICINE INC 8.5%

Value $20.98M Shares 396,115 Est. Cost $47.97 Unrealized -2.1%

AMLX AMYLYX PHARMACEUTICALS INC 8.5%

Value $20.9M Shares 3,260,570 Est. Cost $4.21 Unrealized +15.7%

PCVX VAXCYTE INC 7.2%

Value $17.69M Shares 544,221 Est. Cost $48.83 Unrealized -32.9%

COGT COGENT BIOSCIENCES INC 6.7%

Value $16.5M Shares 2,297,524 Est. Cost $7.59 Unrealized -27.0%

CELC CELCUITY INC 6.4%

Value $15.83M Shares 1,185,520 Est. Cost $15.84 Unrealized -31.3%

CGON CG ONCOLOGY INC 6.2%

Value $15.25M Shares 586,647 Est. Cost $34.79 Unrealized -30.7%

XENE XENON PHARMACEUTICALS INC 5.9%

Value $14.66M Shares 468,364 Est. Cost $39.67 Unrealized -17.8%

DYN DYNE THERAPEUTICS INC 5.6%

Value $13.86M Shares 1,455,429 Est. Cost $11.01 Unrealized 0.0%

MLTX MOONLAKE IMMUNOTHERAPEUTICS 5.6%

Value $13.73M Shares 290,784 Est. Cost $47.43 Unrealized -14.1%

— MERUS N V 4.8%

Value $11.8M Shares 224,260 Est. Cost $35.99 Unrealized —

CNTA CENTESSA PHARMACEUTICALS PLC 4.2%

Value $10.42M Shares 793,327 Est. Cost $13.84 Unrealized —

LENZ LENZ THERAPEUTICS INC 4.1%

Value $10.03M Shares 342,312 Est. Cost $27.20 Unrealized 0.0%

NBIX NEUROCRINE BIOSCIENCES INC 3.0%

Value $7.313M Shares 58,181 Est. Cost $114.68 Unrealized 0.0%

OCUL OCULAR THERAPEUTIX INC 2.7%

Value $6.761M Shares 728,576 Est. Cost $8.25 Unrealized -5.2%

ASND ASCENDIS PHARMA A/S 2.7%

Value $6.592M Shares 38,191 Est. Cost $128.89 Unrealized —

ARGX ARGENX SE 2.3%

Value $5.669M Shares 10,285 Est. Cost $394.09 Unrealized —

ABVX ABIVAX SA 1.9%

Value $4.762M Shares 622,479 Est. Cost $13.48 Unrealized —

SNDX SYNDAX PHARMACEUTICALS INC 1.9%

Value $4.688M Shares 500,551 Est. Cost $18.17 Unrealized -39.4%

NAMS NEWAMSTERDAM PHARMA COMPANY 1.6%

Value $3.997M Shares 220,695 Est. Cost $19.89 Unrealized -8.3%

CTNM CONTINEUM THERAPEUTICS INC 0.5%

Value $1.268M Shares 319,348 Est. Cost $15.90 Unrealized -72.7%

REPL REPLIMUNE GROUP INC 0.5%

Value $1.198M Shares 128,917 Est. Cost $8.73 Unrealized 0.0%

KALV KALVISTA PHARMACEUTICALS INC 0.3%

Value $710K Shares 62,793 Est. Cost $7.51 Unrealized +62.7%

SLN SILENCE THERAPEUTICS PLC 0.1%

Value $201K Shares 34,737 Est. Cost $11.10 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
JAZZ	JAZZ PHARMACEUTICALS PLC	206,952	$21.96M	8.9%	$108.63	0.0%	SHS USD	G50871105
IRON	DISC MEDICINE INC	396,115	$20.98M	8.5%	$47.97	-2.1%	COM	254604101
AMLX	AMYLYX PHARMACEUTICALS INC	3,260,570	$20.9M	8.5%	$4.21	+15.7%	COM	03237H101
PCVX	VAXCYTE INC	544,221	$17.69M	7.2%	$48.83	-32.9%	COM	92243G108
COGT	COGENT BIOSCIENCES INC	2,297,524	$16.5M	6.7%	$7.59	-27.0%	COM	19240Q201
CELC	CELCUITY INC	1,185,520	$15.83M	6.4%	$15.84	-31.3%	COM	15102K100
CGON	CG ONCOLOGY INC	586,647	$15.25M	6.2%	$34.79	-30.7%	COM	156944100
XENE	XENON PHARMACEUTICALS INC	468,364	$14.66M	5.9%	$39.67	-17.8%	COM	98420N105
DYN	DYNE THERAPEUTICS INC	1,455,429	$13.86M	5.6%	$11.01	0.0%	COM	26818M108
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	290,784	$13.73M	5.6%	$47.43	-14.1%	CLASS A ORD	61559X104
—	MERUS N V	224,260	$11.8M	4.8%	$35.99	—	COM	N5749R100
CNTA	CENTESSA PHARMACEUTICALS PLC	793,327	$10.42M	4.2%	$13.84	—	SPONSORED ADS	152309100
LENZ	LENZ THERAPEUTICS INC	342,312	$10.03M	4.1%	$27.20	0.0%	COM	52635N103
NBIX	NEUROCRINE BIOSCIENCES INC	58,181	$7.313M	3.0%	$114.68	0.0%	COM	64125C109
OCUL	OCULAR THERAPEUTIX INC	728,576	$6.761M	2.7%	$8.25	-5.2%	COM	67576A100
ASND	ASCENDIS PHARMA A/S	38,191	$6.592M	2.7%	$128.89	—	SPONSORED ADR	04351P101
ARGX	ARGENX SE	10,285	$5.669M	2.3%	$394.09	—	SPONSORED ADR	04016X101
ABVX	ABIVAX SA	622,479	$4.762M	1.9%	$13.48	—	SPONSORED ADS	00370M103
SNDX	SYNDAX PHARMACEUTICALS INC	500,551	$4.688M	1.9%	$18.17	-39.4%	COM	87164F105
NAMS	NEWAMSTERDAM PHARMA COMPANY	220,695	$3.997M	1.6%	$19.89	-8.3%	ORDINARY SHARES	N62509109
CTNM	CONTINEUM THERAPEUTICS INC	319,348	$1.268M	0.5%	$15.90	-72.7%	CL A	21217B100
REPL	REPLIMUNE GROUP INC	128,917	$1.198M	0.5%	$8.73	0.0%	COM	76029N106
KALV	KALVISTA PHARMACEUTICALS INC	62,793	$710K	0.3%	$7.51	+62.7%	COM	483497103
SLN	SILENCE THERAPEUTICS PLC	34,737	$201K	0.1%	$11.10	—	ADS	82686Q101